Table 4.
Comparison of reported retinal vein occlusion prevalence rates in the United States
| Study |
Prevalence
of BRVO |
Prevalence
of CRVO |
Prevalence
of any RVO |
Subjects |
Communities
sampled |
|---|---|---|---|---|---|
| ARIC + CHS6 | 0.25% | 0.05% | 0.3% | 15466 | 6 |
| BDES7 | 0.6% | 0.1% | 0.7% | 4856 | 1 |
| MESA8 | 0.9% | 0.2% | 1.1% | 6147 | 6 |
| NHANES | 0.42% | 0.08% | 0.50% | 5559 | 30 |
ARIC indicates Atherosclerosis Risk in Communities Study; BDES, Beaver Dam Eye Study; BRVO, branch retinal vein occlusion; CHS, Cardiovascular Health Study; CRVO, central retinal vein occlusion; MESA, Multi-Ethnic Study of Atherosclerosis; NHANES, National Health and Nutrition Examination Survey; RVO, retinal vein occlusion.